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Insulin is produced and stored inside the pancreatic β-cell secretory
granules, where it is assumed to form Zn2+-stabilized oligomers. However,
the actual storage forms of this hormone and the impact of zinc ions on
insulin production in vivo are not known. Our initial X-ray fluorescence
experiment on granules from native Langerhans islets and insulinoma-
derived INS-1E cells revealed a considerable difference in the zinc content.
This led our further investigation to evaluate the impact of the intra-granular
Zn2+ levels on the production and storage of insulin in different model
β-cells. Here, we systematically compared zinc and insulin contents in the
permanent INS-1E and BRIN-BD11 β-cells and in the native rat pancreatic
islets by flow cytometry, confocal microscopy, immunoblotting, specific mes-
senger RNA (mRNA) and total insulin analysis. These studies revealed an
impaired insulin production in the permanent β-cell lines with the dimin-
ished intracellular zinc content. The drop in insulin and Zn2+ levels was
paralleled by a lower expression of ZnT8 zinc transporter mRNA and ham-
pered proinsulin processing/folding in both permanent cell lines. To
summarize, we showed that the disruption of zinc homeostasis in the
model β-cells correlated with their impaired insulin and ZnT8 production.
This indicates a need for in-depth fundamental research about the role of
zinc in insulin production and storage.
1. Introduction
Insulin is one of the key hormones responsible for carbohydrate homeostasis
and metabolic response. Insulin is synthesized in the endoplasmic reticulum
(ER) as a 110 amino acid preproinsulin. The cleavage of its signal sequence
yields 81 amino acid proinsulin that is transported into the Golgi apparatus,
in which the immature—proinsulin-containing—insulin secretory granules
(ISGs) are formed that dominate the content of the β-cell [1]. For example, the
rodent β-cell contains approximately 10 000 ISGs of 300–500 nm diameter
(approx. 10–20% of its total cell volume [2]), with each granule storing about
200 000 insulin molecules [3]. It is envisaged that proinsulin firstly forms
there, soluble Zn2+-stabilized hexamers, which are finally processed into a
fully functional, mature 51 amino acid two-chain insulin molecule that is still
© 2020 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
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held in the Zn2+-maintained hexamer [4–7]. It is thought that
the proinsulin→ insulin hexamer transition lowers the solubi-
lity of the resulting insulin oligomers, which subsequently
form some crystalline material [8].
The in vitro studies showed that different types of insulin
hexamers have in vitro distinctive thermodynamic stabilities
[9,10], hence the prevalence of a specific type of insulin
oligomer in the ISGs could have an impact on the insulin
pancreas→ bloodstream secretion process, i.e. the bioavail-
ability of this hormone. However, despite the abundance of
in vitro studies of insulin, there is still a lack of direct, exper-
imental in vivo evidence for the type of storage form of
insulin, e.g. of particular insulin crystals in the β-cells, and
the indication of a specific, oligomeric form of the hormone.
This long-standing uncertainty—almost 100 years—about
the in vivo structural (presumably crystalline) form of the ISG
stored insulin, and our long-term interest in the insulin struc-
ture–function relationship [11–15] prompted our trials to
address this challenge, and to elucidate the quaternary struc-
ture of insulin in live ISGs. These trials were encouraged by
the development of cutting-edge high-brilliance radiation syn-
chrotron sources and detectors. We initiated this research by
the X-ray fluorescence (XRF) analysis of the isolated ISGs
from rat pancreas and rat-origin permanent INS-1E β-cells.
The selection of the material was also dictated by the need
for the most feasible and ethical source of ISGs (INS-1E
β-cells) for these very material-demanding studies. Surpris-
ingly, the XRF scans revealed a remarkable difference in Zn2+
content between INS-1E and native rat pancreatic islets’ ISGs.
Although the non-standard insulin production in the perma-
nent insulinoma-derived β-cell lines is well known, the actual
lack of Zn2+ in their storage granules was unexpected.
These preliminary findings highlighted the need for a
much more in-depth focus on Zn-ISG content in the context
of the insulin issue, and hence prompted the main research
aims addressed in this report: (i) detailed characterization of
Zn2+ ions’ content in model β-cells, and (ii) elucidation of the
role of Zn2+ in β-cell insulin production. We performed an in-
depth, comparative characterization of different β-cell
models: rat-derived permanent INS-1E and BRIN-BD11 cell
lines and rat pancreatic islets as a source of native β-cells.
Again, the feasibility of the ISG yield and the widespread use
of these cell lines were the main factors in their selection. The
results obtained in this study revealed a striking correlation
between levels of intracellular Zn2+ in the studied β-cells and
their ability for effective folding and production of insulin,
also evoking questions about the causative links between
impaired, pathological insulin production and zinc deficiency.
2. Results
2.1. Isolation of insulin secretory granules
The purpose of the isolation was to obtain the human-
homologous, native-like insulin-containing material that was
used for the initial analysisof thezinccontentbyXRF(seebelow).
The ISGs were isolated by a discontinuous Nycodenz and
the subsequent Percoll gradients, where the ISGs were loca-
lized on dot-blots by the insulin (L6B10) mouse mAb
(no. 8138). Both gradients yielded 13 fractions (figure 1),
with fractions N8 and N9 of the Nycodenz gradient showing
the largest amount of insulin (figure 1a). Hence they were
separated further by the Percoll gradient. The highest level
of insulin was observed in fractions P11-P13 (figure 1b),
which were considered as purified ISGs and used for further
experiments. The identity of the ISGs was verified on Western
blots using both anti-insulin and anti-chromatogranin A anti-
bodies (figure 2), as 21 kDa betagranin (the N-terminal
fragment of chromatogranin A) is one of the characteristic
components of ISGs [16].
2.2. Transmission electron microscopy
Rat pancreatic islets and both permanent INS-1E and BRIN-
BD11 cell lines were examined by transmission electron
microscopy (TEM). The INS-1E and BRIN-BD11 cell lines
displayed a highly reduced number of ISGs (marked by
arrows in figure 3a–d) in comparison with the rat islet cells
(figure 3e,f ). They also lacked a clear visible halo, which is
characteristic of mature ISGs. The absence of a dense core
formed by processed insulin surrounded by a lucent and
well-defined halo could be a marker of the presence of pro-
insulin, which is typically localized in the peri-nuclear
region of the ISGs [17]. The permanent cell ISGs are also sub-
stantially smaller than rat islets ISGs. The size of rat ISGs was
between 250 and 300 nm, while the diameter of INS-1E cells’
granules was only between 150 and 200 nm, with the size of
some BRIN-BD11 ISGs even below 100 nm.
(a)
(b)
Figure 1. Dot-blot analysis of fractions obtained by the ultracentrifugation of
insulin secretory granules from INS-1E cells. Insulin was quantified in each of
the 13 fractions obtained by Nycodenz (a) or Percoll (b) gradients. Fractions







Figure 2. Western blot analysis of INS-1E cells granule fraction preparation.
INS-1E cell lysate (2 µg) and isolated granule fraction (2 µg) were separated
on 12% gel and tested with anti-actin, anti-chromogranin A and anti-insulin
antibodies. Two blots developed from the identical sample are shown but






Rat pancreatic islets displayed a large number of β-cells
with a dense core, mature ISGs and a translucent halo
(marked by arrows in figure 3e). Some immature ISGs,
slightly larger in size than mature ISGs, and with a low, or
intermediate, density (marked by arrows in figure 3f ) were
also observed there. The scattered lamellar ER, Golgi appar-
atus and numerous mitochondria were also well visible in
the rat islet β-cells (figure 3).
2.3. Analysis of insulin secretory granules from INS-1E
cells by X-ray fluorescence
The rat and INS-1E β-cells ISGs were also examined by XRF.
The XRF scan of the ISGs from the rat β-cells showed the pres-
ence of zinc (marked by arrows in figure 4a), whereas the XRF
scan of the ISG sample from the INS-1E cells did not indicate
any presence of these ions (figure 4b).
2.4. Determination of zinc content in INS-1E cells using
atomic absorption spectroscopy (inductively
coupled plasma-optical emission spectroscopy)
The Zn2+ content in the INS-1E cells was investigated by
inductively coupled plasma-optical emission spectroscopy
(ICP-OES), where the impact of media-zinc supplementation
on their intracellular Zn2+ concentration and their growth
was evaluated. The 72 h exposure of the cells to ZnCl2-
supplemented (0.0–0.6 mM) medium gave a sigmoidal
Zn2+ concentration-dependent intracellular increase of
these ions (figure 5). This increase was most significant
within the 0.2–0.4 mM concentration of ZnCl2 in the
medium. However, the increase of Zn2+ in the medium
also had a negative effect on the growth and proliferation
abilities of the INS-1E cells. Their numbers decreased
rapidly with increasing zinc concentrations, reaching a
(a) (b)
(c) (d)
(e) ( f )
Figure 3. Transmission electron microscopy images of BRIN-BD11 cells (a,b), INS-1E cells (c,d), and rat pancreatic islets (e,f ). (a,c and e) Show cells magnified 10 000





plateau within the 0.2–0.4 mM Zn2+ range, declining finally
to approximately 10% of their initial number at 0.4–0.6 mM
Zn2+. The concentration of Zn2+ above 0.8 mM was lethal to
the cells. Subsequently, this increasing Zn2+ cell toxicity
helped to establish its low—50 µM ZnCl2—level of the
INS-1E and BRIN-BD cells’ growth media for the sub-
sequent flow cytometry and confocal fluorescence
microscopy experiments.
2.5. Flow cytometry
Fluorescent cell-permeant FluoZin-3AM high Zn2+ affinity
probe (Kd value approx. 15 nM) was used for the visualiza-
tion of the intracellular Zn2+ in flow cytometry experiments
in the INS-1E, BRIN-BD11 cells, and in the dispersed native
rat pancreatic cells. The effect of the cell-permeable Zn2+
chelator TPEN (Kd approx. 3.8 × 10
−15 M) [19] on the
quenching of FluoZin-3AM was also investigated. The
fluorescence intensity of the untreated cells (autofluores-
cence) was determined first, followed by determination
of the fluorescence of the TPEN- and, subsequently,
FluoZin-3AM-pretreated cells. Finally, the fluorescence of
FluoZin-3AM-only-treated cells was measured as well.
All types of cells showed an increase in fluorescence
intensity after treatment with FluoZin-3AM, when compared
to the basal autofluorescence of the untreated cells, with a
substantial reduction in FluoZin-3AM fluorescence in all
cell types after pre-treatment with zinc chelator TPEN
(table 1). The intensity of FluoZin-3AM fluorescence of rat
pancreatic β-cells was approximately 5–8 times higher than
the intensity of fluorescence in INS-1E or BRIN-BD11 cells,
respectively (table 1, figure 6a). To assess the effect of
the supplementation of the cells by additional Zn2+ ions






































Figure 4. XRF spectra of the ISGs isolated from rat islets (a) and INS-1E cells (b). In (a), the signal of zinc is marked by an arrow. The large double peaks on the
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Figure 5. Effects of ZnCl2 supplementation on growth of INS-1E cells





the untreated and 50 µM ZnCl2 pretreated INS-1E and BRIN-
BD11 cells. Here, this Zn-enrichment of the media had a
negligible effect on FluoZin-3AM-related cell fluorescence
(figure 6b,c).
2.6. Confocal fluorescence microscopy
Cell-permeant fluorescent probe FluoZin-3AM was also
employed to detect the intracellular zinc ions by confocal fluor-
escencemicroscopy (CFM),with zinc chelator TPENused again
as a ‘negative’ control. Confocal images of the cells (INS-1E,
BRIN-BD11 and dispersed rat pancreatic islet cells) were taken
after staining with FluoZin-3AM only (figure 7b,d,f), or in the
co-presence of TPEN and FluoZin-3AM (figure 7a,c,e).
The cells revealed significant differences by CFM in their
intracellular zinc content, with the BRIN-BD11 cells showing
the lowest, and the islet cells the highest fluorescence. The use
of TPEN reversed the FluoZin-3AM-dependent fluorescence
in all types of cells to its almost basal levels.
2.7. Tricine-sodium dodecyl sulphate–polyacrylamide
gel electrophoresis and Western blot analysis of
insulin in cell samples
To align the fluorescence-based assessment of Zn2+ presence
in the ISGs to the context of their insulin content, the appear-
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Figure 6. Flow cytometry experiments. (a) Intensity of fluorescence of INS-1E cells (green), BRIN-BD11 cells (blue) and rat native pancreatic islet cells (red). Com-
parison of the intracellular zinc content in INS-1E (b) and in BRIN-BD11 cells (c) measured as the intensity of fluorescence of cells grown in medium supplemented
with (darkly coloured bars) or without (lightly coloured bars) 50 µM ZnCl2. The left bar in each light or dark colour set shows autofluorescence in untreated cells, the
middle bar, fluorescence of the cells treated with TPEN/FluoZin-3AM and the right bar, fluorescence in the cells treated by FluoZin-3AM only.
Table 1. Autofluorescence of INS-1E, BRIN-BD11 and rat pancreatic islet
cells, and their fluorescence after treatment with FluoZin-3AM/TPEN or with
FluoZin-3AM probe only. (The data are the means of four or three










autofluorescence 140 ± 7 (4) 216 ± 8 (4) 867 ± 22 (3)
FluoZin-3AM 4311 ± 320 (4) 2499 ± 174 (4) 21590 ± 2768 (3)
FluoZin-3AM +
TPEN





and in the rat pancreatic islets was analysed by Western
blotting, after separation of the proteins by non-reducing
tricine-sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE). The insulin content was tested in
both 50 µM ZnCl2-treated and untreated BRIN-BD11 and
INS-1E cells. As expected, insulin was observed in the rat
Langerhans islets (figure 7, lines 13 and 14) and in homogen-
ates of the INS-1E cells (figure 7, lines 5 and 6). However, the
ZnCl2-treated INS-1E cells (figure 8, lines 7 and 8) also
showed—besides insulin—the weaker presence of proinsulin,
and two higher molecular weight protein bands (marked by
asterisks in figure 8) with the intensities comparable to the
insulin band. By contrast, the BRIN-BD11 cells did not show
any detectable insulin-positive bands (figure 8, lines 9–12).
Besides insulin and proinsulin, the INS-1E cells also
contain other unidentified proteins with higher molecular
weights (figure 8, proteins marked by asterisks). Despite
repeated attempts at N-terminal amino acid sequencing,
tryptic digestion/mass spectrometry (MS) analysis or immu-
noprecipitation, these proteins could not be unequivocally
identified. However, the MS data of the proteolytic digests
of the lower (10 kDa) band showed only the presence of insu-
lin fragments, and no other proteins (data not shown).
2.8. Expression of insulin messenger RNA in cell
samples
To achieve an alternative parameter for the assessment of
insulin abundance in the studied cells (and the isolated rat
pancreatic islets), their insulin messenger RNA (mRNA)
expression levels were determined and compared (figure 9).
These indicated remarkable differences between a very high
expression of insulin mRNA in native rat islets, and approxi-
mately 70- and, especially approximately 30 000-fold lower
insulin expression in INS-1E or BRIN-BD11 cells, respectively.
2.9. Analysis of the total insulin content in permanent
cells and Langerhans islets
To complete the estimation of insulin in the studied cells and




Figure 7. Confocal microscopy images of BRIN-BD11 cells (a,b), INS-1E cells (c,d), and rat pancreatic islets (e,f ): pretreated with TPEN (a,c,e) or treated with





insulin’s mRNA, and their total insulin contents were deter-
mined by radioimmunoassay (RIA). The logarithmic scale
summary of the total insulin analysis (figure 10) illustrates
a remarkable difference between the very high level of insulin
in native rat islets and the ca. 100- and, especially, approxi-
mately 35 000-fold lower level of total insulin in INS-1E or
BRIN-BD11 cells, respectively.
2.10. Expression of ZnT8 zinc transporter messenger
RNA in cell samples
Finally, the relative expression levels of the zinc transporter
ZnT8 mRNA in isolated rat pancreatic islets, BRIN-BD11 and
INS-1E cells were determined to elucidate whether the Zn2+
transport is disrupted in these cell lines. This revealed that the
expression of ZnT8 in the INS-1E and BRIN-BD11 cells is
markedlydecreased in comparisonwith the rat islets (figure 11).
3. Discussion
Owing to its central location at the crossroads of metabolism,
growth and lifespan regulation, human insulin has been
the subject of intense research since the discovery of this hor-
mone in 1921. Despite several hundreds of in vitro structures
of this hormone, its in vivo storage form—in ISGs—has, to
date, eluded any characterization. Solid-state and nuclear
magnetic resonance studies led to the general assumptions
that insulin is stored in the ISGs in some form of zinc-stabil-
ized, crystalline or semi-crystalline hexamers [3,20,21]. Such
suppositions were corroborated by reports about high con-
centrations of both zinc and insulin within the ISGs [5,22],
which should favour the formation of insulin hexamer crys-
tals observed in vitro in the presence of Zn2+ ions. However,
there is still a lack of direct in vivo experimental evidence
for insulin crystals in the β-cells and of the indication of an
oligomeric (if any) type of this hormone in ISGs.
We endeavoured to resolve this ambiguity by structural,
high-brilliance X-ray studies of live ISGs. However, the pre-
liminary step of this research—XRF of ISGs isolated from
rat INS-1E cells and rat islets β-cells—showed a lack of Zn2+
ions in the permanent cells, in contrast with a clear Zn-XRF
signal from the whole, native islets (figure 4). This unex-











Figure 8. Western blot analysis of proinsulin and insulin content in rat
pancreatic islets, INS-1E and BRIN-BD11 cells on the non-reducing tricine-
SDS-PAGE separation. Line 1, human insulin (7 ng); line 2, human insulin
(13 ng); line 3, bovine proinsulin (7 ng); line 4, bovine proinsulin (13 ng);
line 5, INS-1E cells homogenate (1.5 µg); line 6, INS-1E cells homogenate
(3 µg); line 7, zinc-supplemented INS-1E cells homogenate (1.5 µg); line
8, zinc-supplemented INS-1E cells homogenate (3 µg); line 9, BRIN-BD11
cells homogenate (1.5 µg); line 10, BRIN-BD11 cells homogenate (3 µg);
line 11, zinc-supplemented BRIN-BD11 cells homogenate (1.5 µg); line 12,
zinc-supplemented BRIN-BD11 cells homogenate (3 µg); line 13, rat pancrea-
tic islets homogenate (0.3 µg); line 14, rat pancreatic islets homogenate
(0.6 µg). Asterisks mark unidentified insulin-immunopositive bands. Control
actin content in the cell lysates is shown at the base of the image. Variable





























Figure 9. RT-PCR analysis of rat insulin mRNA expression in rat pancreatic islets,
INS-1E and BRIN-BD11 cells. The insulin mRNA expression levels (on a logarith-

























Figure 10. Analysis of the total insulin content in rat pancreatic islets, INS-1E


























Figure 11. RT-PCR analysis of rat ZnT8 mRNA expression in rat pancreatic
islets, INS-1E and BRIN-BD11 cells. The ZnT8 mRNA expression levels are





systematic biochemical analysis of the cellular material, prior
to its further structural studies. Therefore, here we firstly
aimed at an analysis of the Zn content in the permanent
INS-1E and BRIN-BD11 cells that could be ethical sources
of ISGs for material-demanding X-ray experiments and com-
pare it with native rat islets. Second, we attempted an
analysis of insulin production in these in vivo systems, to
learn about a potential relationship between the ISGs Zn2+
content on the levels and folding of insulin in these granules.
The permanent β-cell lines derived from insulinomas
for the study of β-cell functions were already the subject of
several studies [23–28]. Although they showed some exper-
imental limitations of these cells e.g. non-standard insulin
production, our initial findings of the potential zinc
deficiency in these cells made them very good targets of com-
parative studies of the presence of intracellular (ISGs) Zn2+ in
the context of the morphology of insulin production and con-
tent. We also employed the same methodologies on the rat
pancreatic islets as a source of reference, native β-cells.
Electron transmission micrographs revealed a substantial
reduction in the number and size of ISGs in both insulinoma
cell lines, especially in BRIN-BD11 cells, in comparison with
rat islets (shown by arrows in figure 3). This is in agreement
with the already reported low insulin content and weak
secretory responses to glucose in BRIN-BD11 cells [29,30].
Also, in contrast with the β-cells in the rat islets, the insuli-
noma INS-1E cells lack the characteristic intra-granular halo
in their ISGs (shown by arrows in figure 3c,d), suggesting
the dominance of an amorphous hormone inside these gran-
ules [3,21]. Such prevalence of an amorphous form of insulin
in these permanent cells may result from an incomplete
proinsulin→ insulin conversion [31], as the proinsulin Zn2+-
stabilized hexamers still remain soluble under granular pH
of approximately 5.7, and only the cleavage of the C-peptide
from proinsulin should yield low-solubility, crystallizable
hexamers of the mature hormone [6,32,33].
Subsequently, the comparative ICP-OES and flow cytome-
try experiments revealed a reduction of zinc content in both
permanent cell lines, in comparison with native rat islet cells
(table 1, figure 6). This deficit can be ameliorated—to some
extent—in the INS-1E cell line by higher medium Zn concen-
trations, but this drastically reduces the viability of these
cells (figure 5). Moreover, supplementation of the medium
with lower ‘safer’ (50 µM) levels of ZnCl2 does not restore
the intracellular zinc levels in the permanent cell lines
(figure 6b,c). Although the data of these observations are in
general agreement with Nygaard et al. [28] and Chimienti
et al. [34], who also used lower than 100 µM Zn2+ supplemen-
tation in INS-1E cells (in order to avoid zinc toxicity), our
results indicate that even a much lower zinc concentration
(approx. 20–50 µM) in the media is cytotoxic to these cells
(figure 5). Moreover, Chimienti et al. [34] also did not observe
any increase of intracellular zinc after supplementation of the
media with 100 µM Zn2+. However, this small effect of 50–
100 µM zinc supplementation is not surprising, if an endogen-
ous, much higher Zn2+ concentration inside the ISGs
(estimated as approximately 10–20 mM) is considered [5].
As the ISG-membrane-localized ZnT8 transporter is the
most important zinc-transporting protein in the β-cells
responsible for the translocation of the cytoplasmic Zn2+
into the ISGs [35,36], the expression of mRNA of this trans-
porter was also measured in all our cell systems. The
markedly decreased, impaired lower levels of ZnT8 mRNA
in the INS-1E and BRIN-BD11 permanent cell lines (figure 10)
suggest that ZnT8 deficiency could indeed contribute to low
intracellular and intra-granular zinc levels.
It should be stressed, however, that the β-cells in the rat
islets were not separated from other endocrine cell types
(α, δ, ε and pancreatic polypeptide cells) also present in this
tissue [37]. Although we attempted to separate these native
β-cells from the collagenase-digested rat islets by fluorescent
activated cell sorting (FACS) (data not shown), these exper-
iments were unsuccessful owing to a prevalent destruction of
all cells. Therefore, assuming that rat islets contain approxi-
mately 70–80% of the β-cells, [38], the actual difference in
Zn2+ content between the rat islet β-cells and the permanent
β-cell lines may probably be even higher. Such an assumption
is further supported here byCFM (figure 7), which clearly indi-
cated intensity differences in zinc-dependent fluorescence
between permanent cells and pancreatic islets. Here, Zn2+-
rich islets contain a distinctive, dense, green fluorescence that
is concentrated in separate clusters in the β-cells (figure 7f ).
As expected, immunoblotting experiments showed high
levels of almost exclusively mature, processed insulin in the
rat islets. By contrast, they indicated a much lower amount of
insulin in INS-1E cells, and, on the threshold of detectability,
in BRIN-BD11.What is interesting, besides insulin andproinsu-
lin, INS-1E cells also contain other unidentified proteins with
higher molecular weights (figure 8, proteins marked by aster-
isks). Despite repeated attempts of the N-terminal amino acid
sequencing, tryptic digestion/MS analysis and immunopreci-
pitation, these proteins could not be unequivocally identified.
However, the MS data of the proteolytic digests of the lower
(10 kDa) band showed only the presence of insulin fragments
and no other proteins (data not shown). This suggests that
these higher molecular weight ‘aggregates’ could be oxidized,
misfolded forms of insulin (or proinsulin), cross-linked by the
mismatched disulfide bonds. The eminent presence of pro-
insulin in INS-1E cells indicates an aberrant (pro)hormone
folding/processing there,which isalsoobserved in insulinomas,
and resulting there in the formation of both proinsulin- and
insulin-containing secretory granules [39–41].
Finally, we also showed a great under-expression of
insulin mRNA (figure 9), in both permanent cell lines;
approximately 70-fold (in INS-1E) and approximately
30 000-fold (in BRIN-BD11) lower, than in rat islets (figure 9).
This coincides with our immunodetection-assessed insulin
levels in the corresponding cell samples (figure 8), also
being in good agreement with our determination of the
total insulin content; approximately 100-fold and approxi-
mately 35 000-fold lower than in rat islets in the INS-1E and
BRIN-BD11 cells, respectively (figure 11). To assure a relevant
comparison of the insulin content, we used a similar—102
islets versus 105 cells—amount of the material.
In summary, our data presented here clearly indicate that
the reduced intracellular zinc levels in the permanent INS-1E
and BRIN-BD11 cells are correlated with an impaired insulin
production, and with a much lower expression of ZnT8
mRNA. However, the exact molecular nature of the mechan-
ism by which zinc levels/ZnT8 deficiency can affect, or even
cause, an altered insulin production and its processing in
these permanent cell lines remains unclear. Nevertheless, it
cannot be excluded that, considering the important role of
Zn2+ in insulin oligomerization in vitro, its deficiency can
impact the effective formation of proinsulin hexamers, there-





This suggests a more extensive role of Zn2+ ions in
insulin production, besides their oligomer-stabilization/
storage role for insulin hexamers and their co-secretion. More-
over, Zn2+ ions are also involved in paracrine and autocrine
communication within the pancreas [6], as, for example, the
repression of glucagon-secreting activity of neighbouring
α-cells [42], contributing also to the regulation of β-cell mass
as a potent inhibitor of the apoptosis [43,44]. Significantly, it
also seems that the disruption of zinc homeostasis is correlated
with impaired insulin sensitivity and signalling, as is often
observed in both type 1 and type 2 diabetes. For example,
diabetic patients often display hypozincaemia [45] or hyper-
zincuria [46], while zinc-deficient rats also exhibit reduced
insulin secretion and glucose sensitivity [47].
Therefore, our results presented here confirm and expand
the ubiquitous role of Zn2+ ions in insulin molecular and cell
biology, and underline the need for further in-depth studies
of their inter-relationship. However, they also underline and
amplify the methodological limitations of the rat permanent
β-cells and their application to structural studies. This is of
special importance for a reliable in vivo model of the β-cell
for effective diabetes research and clinical applications.
4. Methods
4.1. Cell cultures
The rat clonal beta cell line INS-1E [48] AddexBio, San Diego,
CA, USA; Cat no. C0018009), derived from parental INS-1
cells [49], was cultured in a humidified atmosphere contain-
ing 5% CO2 and at 37°C in a complete medium, composed
of RPMI 1640 medium supplemented with 10% heat-inacti-
vated fetal bovine serum (FBS), 1 mM sodium pyruvate,
50 mM 2-mercaptoethanol, 2 mM L-glutamine, 10 mM
HEPES, 100 U ml−1 penicillin and 100 U ml−1 streptomycin.
The clonal beta cell line BRIN-BD11 (Sigma-Aldrich,
St Louis, MO, USA; Cat no. 10033003) is a hybrid cell line,
formedby the electrofusion of a primary culture of rat pancreatic
islets (New EnglandDeaconess Hospital, NEDH) with RINm5F
cells [50,51]. The cell linewasmaintained in a humidified atmos-
phere containing 5% CO2 at 37°C in a complete medium,
composed of RPMI 1640 medium supplemented with 10%
heat-inactivated FBS, 2 mM L-glutamine, 100 U ml−1 penicillin
and 100 U ml−1 streptomycin.
4.2. Isolation of rat pancreatic islets
Islets from male Wistar rats (approx. 400–500 g, 6 months old,
Velaz s.r.o., Czech Republic) were isolated using a previously
described method [52]. Six to eight animals were used for iso-
lation islets only, and 40 animalswere used for isolation of islets
for isolation of ISGs (see below). Briefly, the main pancreatic
duct in an anaesthetised animal was cannulated. After donor
euthanizing, the pancreas was filled with 15 ml of collagenase
(Sevapharma, Prague, Czech Republic, 1 mg ml–1 in HBSS
buffer), before being excised and incubated for 30 min at
37°C. After removal of fat and floating tissue by centrifugation
in HBSS (110g, 5 min, 4°C), the digest was passed through a
sterile 450 µm sieve. Islets were purified using discontinuous
Ficoll (Ficoll 400 DL, Sigma-Aldrich, USA) density gradient
composed of four layers (1.108 g ml−1, 1.096 g ml−1,
1.068 mg l−1, 1.037 mg l−1) and centrifuged at 520g for 20 min.
Isolated islets were then collected from the interlayer of discon-
tinuous Ficoll gradient (1.068/1.096 mg l−1) and then washed
twice in ice-cold Hank’s balanced salt solution (HBSS) to
remove Ficoll. Islets were kept overnight at 37°C in 5 ml of
CMRLmedium (Cellgro;Mediatech,Manassas, VA, USA) sup-
plementedwith 10%FBS or immediately used for experiments.
All animal experiments described in this study were
performed according to the ethical guidelines for animal
experiments and to the EU (86/609/EU) and Czech Republic
Law 246/1992 and were approved by the Committee for
experiments with laboratory animals of the Academy of
Sciences of the Czech Republic (decision no. 38/2013 was
issued on 8/4/2013).
4.3. Isolation of rat pancreatic islet cells
For disintegration of islets to single cells, cultured islets were
rinsed in phosphate buffered saline (PBS) and incubated in
Accutase (Sigma-Aldrich, USA) for 10 min with occasional
pipetting at room temperature (RT). A pellet of cells (approx.
90% of single cells) was resuspended in HBSS buffer, centri-
fuged at 120g for 4 min. The excess of HBSS buffer was
removed. The procedure was repeated twice. The resulting
pellet of dispersed islet single cells was immediately used in
experiments.
4.4. Isolation of secretory granules from INS-1E cells
and pancreatic islets
The isolation of ISGs was performed according to the proto-
col published by Brunner et al. [16]. INS-1E cells were grown
in 150 cm2 dishes until about 6 × 108 cells were obtained, or
islets from 40 rats were used. All the procedures were per-
formed at 4°C. Cells were washed once with PBS and
scraped in cold PBS. Cells were then homogenized in 15 ml
of SMT buffer (0.27 M sucrose, 10 mM MOPS/1 M Tris,
pH 6.8) by three strokes through a 21-G needle, followed
by three strokes through a 25-G needle in order to break
the cells. Cell debris and nuclei were removed by centrifu-
gation for 5 min at 1000g. The supernatant was transferred
to a new tube, and the remaining pellet was homogenized
in 15 ml of SMT by three strokes through a 21-G needle,
followed by five strokes through a 25-G needle. The hom-
ogenate was centrifuged for 5 min at 1000g, and the
resulting supernatant was pooled with the first one. The
pooled supernatants were finally centrifuged for 10 min at
1000g to obtain the post-nuclear supernatant (PNS). The
PNS was centrifuged at 24 700g for 20 min to separate
organelles from the cytosol. The resulting pellet was resus-
pended in SMT, loaded on a discontinuous Nycodenz
gradient composed of three layers (23.4, 8.8 and 4.4%
w/v Nycodenz in SMT buffer, pH 6.6) and centrifuged at
107 000g for 75 min. The presence of insulin granules within
the gradient was followed, using dot-blot with anti-insulin
antibody (L6B10, Cell Signalling). The cloudy ISG fraction
(at about one-third of the tube height, fractions N8-N10 in
figure 1) was recovered and the volume was adjusted to
10 ml with SMT. This suspension was loaded on 27% w/v
Percoll solution, which was centrifuged at 35 000g for
45 min. The ISG fraction near the bottom of the tube (fraction
P13 in figure 1) was recovered and washed three times with





ISGs were finally re-suspended in 100 µl of SMT. Protein con-
tent was determined by the Bradford assay. The isolated
granules were separated on SDS-PAGE (12% gels) and
checked for insulin and betagranin (anti-chromogranin A
antibody directed against N terminal amino acids, ab45179,
abcam) content, using the standard Western blot procedure.
4.5. Chemical fixation of cell samples and transmission
electron microscopy
INS-1E cells, BRIN-BD11 cells and freshly isolated rat islets
were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate
buffer (pH 7.5) at RT for 15 min. Then the cells were har-
vested and centrifuged at 800g for 5 min and islets were
centrifuged at 120g for 4 min. A new batch of 2.5% glutaral-
dehyde in 0.1 M cacodylate buffer was added and then the
pellets were post-fixed in 1% osmium tetroxide, dehydrated
in ethanol and embedded in Agar 100 epoxy resin. Ultrathin
sections (70 nm) of cells were cut with a diamond knife on a
Leica UC6 ultra microtome (Leica Microsystems, Wetzlar,
Germany). The thin sections were collected on Parlodion-
coated microscopy grids and contrasted, using saturated
uranyl acetate and lead citrate [53]. The samples were ana-
lysed with a transmission electron microscope JEOL JEM-
1011 device at 80 kV beam acceleration voltage.
4.6. Determination of zinc content in INS-1E cells by
atomic absorption spectroscopy (inductively
coupled plasma-optical emission spectroscopy)
Briefly, 106 INS-1E cells were plated in six-well plates and the
cells were treated with 0.0–1.0 mM ZnCl2 in complete media
for 72 h. The duplicates of each concentration were used.
After 72 h, the cells were trypsinised, counted and washed
three times with PBS. Then 105 cells from each well were
diluted with PBS and the intracellular zinc concentration
in cells was determined by ICP-OES. The ICP-OES measure-
ments were performed using the SPECTRO ARCOS optical
emission spectrometer (SPECTRO Analytical Instruments,
Kleve, Germany) with a radial plasma observation. The
SPECTRO ARCOS features a Paschen-Runge spectrometer
mount; the wavelength range between 130 and 770 nm can
be simultaneously analysed. Zinc ions were determined
using analytical line at 213.85 nm.
4.7. Analysis of isolated insulin secretory granules from
INS-1E cells and rat pancreatic islets by X-ray
fluorescence
Isolated rat islets and ISGs from INS-1E cells were loaded into
special X-ray capillaries (1.0 mm diameter, 0.01 mm wall
thickness (Capillary Tube Supplies, Bodmin, UK)), and
their wide ends were sealed with Parafilm. They were then
mounted in custom-made foam-filled 50 ml plastic containers
(Sarsted) and centrifuged for 8 h at 3800g. The foam filling
and the g force/time was optimized to prevent capillary
breaking, while allowing the concentration of the biological
material. The supernatant was discarded and the capillaries
were cut close to the precipitate of the granules and sealed
with hot wax. They were mounted on the goniometer at
Diamond Light Source (Didcot, UK) and two XRF spectra
were taken [54]. The energy of the incoming X-ray beam
was at 12.658 keV. The exposure time was fixed at 1 s,
while the beam attenuation was set so as to avoid saturation
of the fluorescence detector.
4.8. Flow cytometry
INS-1E and BRIN-BD11 cells were cultured for 72 h in 24-well
plates in a complete RPMI medium, supplemented or not
with 50 µM ZnCl2. The medium was removed, and cells
were rinsed by fresh RPMI and subsequently incubated in
trypsin/EDTA solution for 5 min to release adherent cells
from the surface. Cells were transferred into HBSS buffer
and centrifuged at 250g for 5 min. This procedure was
repeated twice. In parallel, the fresh single-cell suspension
from rat pancreatic islets was prepared as described above.
Thereafter, the cell samples were incubated (at 105 cells per
100 µl) for 30 min on ice with 5 µM zinc-specific fluorescent
probe FluoZin-3AM (Invitrogen) and 30 nM Pluoronic F-127
(Invitrogen) in the HBSS buffer (Thermo Fisher Scientific). In
parallel, to determine the specificity of FluoZin3-AM for
chelatable Zn2+, the cells were also incubated for 30 min at
RT with 50 µM zinc chelator N,N,N’,N’-tetrakis-(2-pyridyl-
methyl) ethylenediamine (TPEN, Sigma-Aldrich, USA)
followed by incubation with FluoZin-3AM and Pluoronic
F-127. After incubation, the samples were washed twice with
HBSS buffer again. Then, 100 µl of cell suspension (containing
approximately 105 cells) was placed into wells of a polypropy-
lene 96-well plate (round bottom). Samples were analysed
with a BD LSR Fortessa™ cell analyser (Becton, Dickinson
and Company) operated by BD FACS Diva™ Software. The
gates on the side scatter and forward scatter were set to
ensure the measurement of viable cells, and 10 000 events
were measured for each well. All variants of experiments
(different staining agents, both cell lines and rat pancreatic
islet cells) were performed in triplicates or tetraplicates and
the results were presented as means with standard deviations.
4.9. Confocal microscopy of fluorescently labelled cells
INS-1E and BRIN-BD11 cells were grown in four-chamber
35 mm glass bottom dishes (In Vitro Scientific). After 3
days, the cells were washed twice with HBSS buffer and
one chamber of each dish was treated with 50 µM TPEN for
30 min. Thereafter, the cells were incubated with 5 µM Fluo-
Zin-3AM (Invitrogen) and 30 nM Pluoronic F-127 in HBSS
buffer for 30 min at RT. Finally, the cells were washed twice
with 200 µl of HBSS.
Confocal images (pinhole 1 Airy unit) of cells in each
chamber were taken with a LSM 780 confocal microscope (Carl
Zeiss Microscopy), using an oil-immersion objective (Plan-
Apochromat 63×/1.40 Oil DIC M27). The fluorescent images
were collected at RT, using 4.5% of the 405 nm diode laser
(max. power 30 mW) for excitation, with emission collected
from 410 to 585 nm (voltage on detector 850 V) for Hoechst
34580, and 4.0% of the 488 nm argon-ion laser (max. power
25 mW) for excitation, with emission collected from 517 to
534 nm (voltage on detector: 870 V) for ATTO488. All images
were taken using the same settings. The FluoZin-3AMmaxima
for excitation and emission are at 488 nm and 525 nm, respect-
ively. The microscope was operated and the images were





4.10. Tricine-sodium dodecyl sulphate-polyacrylamide
gel electrophoresis
One hundred isolated islets (about 1 000 cells per islet) and
100 000 cells from both cell lines (INS-1E and BRIN-BD11)
were dissolved in denaturing buffer (7 M urea, 2 M thiourea,
4% (w/v) CHAPS and 50 mM dithiothreitol, 0.8%). The
protein content was determined using the Bradford assay.
Cell lysates were analysed using electrophoresis. Separation
of proteins smaller than 15 kDa was achieved, using 16%
acrylamide separation gel in combination with 10% spacer
gel and 4% stacking gel in a Tricine-Tris buffer system essen-
tially according to Schägger et al. [55]. Proteins were
transferred to 0.2 µm PVDF membrane (BioRad) in 25 mM
Tris, 192 mM glycine and 20% (v/v) transfer buffer pH 8.3
at 12 V, 0.4 mA cm−2 overnight. Blots were developed by
standard protocol, using anti-insulin antibody (L6B10, Cell
Signalling) and anti-actin (20–33) antibody (Sigma).
4.11. RNA extraction and complementary DNA synthesis
Extraction andpurification ofRNA fromcells or pancreatic islets
wasperformed,usingRNAzolRT (Sigma-Aldrich,USA)accord-
ing to the manufacturer’s instructions. RNA concentration was
measured by ultraviolet absorbance at 260 nm with Nano-
drop2000 (Thermo Fisher Scientific, USA). After extracting the
total RNA, 500 ng of RNA was transferred to a new tube and
heated up to 65°C for 5 min and then, transferred to ice immedi-
ately todenature the secondarystructure ofRNAand to improve
reverse transcription efficiency. First-strand complementary
DNA (cDNA) was synthesized from 500 ng of total RNA,
using ReadyScript cDNA synthesis Mix (Sigma-Aldrich, USA)
as described in the product manual. Briefly, ReadyScript
cDNASynthesisMixwas added toRNAsamples and incubated
at 25°C for 5 min, and next at 42°C for 30 min, at 85°C for 5 min,
then held at 4°C. After completion of reverse transcription, the
synthesized cDNAwas five times diluted with water.
4.12. Quantitative real-time reverse transcription-
polymerase chain reaction
Real-time reverse transcription-polymerase chain reaction (RT-
PCR) was performed using the LightCycler480 (Roche Diag-
nostics, Mannheim, Germany). Final primer concentrations in
the reaction mixture were 0.5 µM. The reversely transcribed
reaction product (corresponding to 20 ng of RNA) in 2 µl was
applied on LightCycler 8-tube strips (Roche Diagnostics,
Germany). The total reaction volume was 20 µl. PCR was per-
formed with the LightCycler 480 SYBR Green I Master (Roche
Diagnostics) and by monitoring an increase in fluorescence of
the SYBRGreenDye. cDNAwas amplified byPCRwith the fol-
lowing primers: glyceraldehyde-3-phosphate dehydrogenase
(gapdh), direct 50 – caccatcttccaggagcgag – 30, reversed 50 –
ggcggagatgatgacccttt – 30, ZnT8 direct 50 – tcgagcagagatcctcggt
– 30, reversed 50 – caagatgccgttggtgcaaa – 30 and rat insulin 1
(Ins1) and 2 (Ins2), direct 50 – accatcagcaagcaggtcat – 30,
reversed 50 – gtttgacaaaagcctgggca – 30. Rat insulins 1 and 2
share similar mRNA sequences, which allows one primer
pair to measure the total insulin mRNA expression level.
mRNAs of insulin and ZnT8 were normalized against
GAPDH. The identity of the PCR products was confirmed by
carrying out electrophoresis on 2.0% agarose gels.
4.13. Analysis of total insulin in BRIN-BD11 and INS-1E
cells and islets of Langerhans
The total content of insulin inside the cells was measured by
acid ethanol extraction [56]. The 102 islets or the 105 cells were
sonicated in 30 µl of water for 15 s. The sonicates were mixed
with acid ethanol (0.18 M HCl in 96% ethanol) in 1 : 3 pro-
portion of sonicate and acid ethanol (90 µl). The mixed
solutions in a total volume of 120 µl were incubated at 4°C
for 12 h. After incubation, the samples were centrifuged at
14 000g for 5 min and the supernatants transferred to new
tubes. The total insulin in the supernatants was measured
by a sensitive rat insulin RIA (Millipore, Missouri, USA),
according to the manufacturers’ instructions.
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